A STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ABT-450/RITONAVIR/ABT-267; (ABT-267 ALSO KNOWN AS OMBITASVIR) AND ABT-333 (ALSO KNOWN AS DASABUVIR) COADMINISTERED WITH RIBAVIRIN (RBV) IN HEPATITIS C VIRUS (HCV) GENOTYPE 1-INFECTED ADULTS WITH COMPENSATED CIRRHOSIS: